Abstract
Our aim in this study was to perform a cost-effectiveness analysis (CEA) to compare myocardial perfusion magnetic resonance imaging (p-MRI) and single photon emission computed tomography (SPECT) in the Japanese setting. The CEA of p-MRI and SPECT was performed from the payer’s perspective. The subjects were outpatients who had chest pain, had no history of myocardial infarction, and showed normal or equivocal stress electrocardiogram findings. The costs of imaging techniques and treatments were assessed with the use of reimbursements of medical fees from Japanese healthcare insurance for the year 2007. Clinical effectiveness was defined in terms of the percent correct diagnosis of coronary artery disease (CAD). Data from published studies provided probabilities for the CEA, including the sensitivity and specificity of each imaging modality. We evaluated the cost-effectiveness ratio (CER) of p-MRI and SPECT using a decision tree model and compared the two. The CERs for diagnosis of CAD by p-MRI and SPECT were 1,988.2 and 2,582.0 Japanese Yen (JPY), respectively. The CERs for diagnosis and treatment of CAD by p-MRI and SPECT were 7,066.1 and 7,172.2 JPY, respectively. At a pre-test likelihood of CAD of 20–70 %, the CERs for diagnosis of CAD by p-MRI and SPECT were 1,476.8–3,364.3 and 2,107.3–3,957.7 JPY, respectively. For outpatients with chest pain, p-MRI had good clinical effectiveness and cost-effectiveness compared with SPECT. In the management of patients with suspected CAD, p-MRI is as useful as SPECT.
Similar content being viewed by others
References
Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med. 1999;130:709–18.
Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108:432–7.
Takase B, Nagata M, Kihara T, Kameyawa A, Noya K, Matsui T, Ohsuzu F, Ishihara M, Kurita A. Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease. Jpn Heart J. 2004;45:475–86.
Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, Klimek W, Oswald H, Fleck E. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379–83.
Iwata K, Kubota M, Ogasawara K. Comparison with myocardial perfusion MRI and myocardial perfusion SPECT in the diagnostic performance of coronary artery disease: a meta-analysis. Nippon Hoshasen Gijutsu Gakkai Zasshi. 2008;64:251–58. (in Japanese). http://nv-med.mtpro.jp/jsrt/selected/pdf/2601/20086402-1.pdf (English version).
Hayashino Y, Shimbo T, Tsujii S, Ishii H, Kondo H, Nakamura T, Nagata-Kobayashi S, Fukui T. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines. Int J Cardiol. 2007;118:88–96.
Ohtomo K. Reimbursement in Japan. Eur Radiol. 2000;10:S424–5.
Kosuda S, Ichihara K, Momiyama Y, Ohsuzu F, Kusano S. Cost-effectiveness of exercise 201Tl myocardial SPECT in patients with chest pain assessed by decision-tree analysis. Kaku Igaku. 1999;36:715–23. (in Japanese).
Uehara A, Hayashi H, Kurata C. Kyoketsusei shinshittukan hyouka chiryou ni okeru shinkin ketsuryu SPECT no yakuwari: cost-effectiveness no kanten kara. Jyunkanki Senmon I. 2003;11:261–6. (in Japanese).
Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, Lehrke S, Merten C, Lossnitzer D, Radeleff J, Zugck C, Giannitsis E, Katus HA. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol. 2010;56:1225–34.
Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115:1769–76.
Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging. 2008;35:319–28.
Lozner EC, Johnson LW, Johnson S, Krone R, Pichard AD, Vetrovec GW, Noto TJ. Coronary arteriography 1984–1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. II. An analysis of 218 deaths related to coronary arteriography. Cathet Cardiovasc Diagn. 1989;17:11–4.
Nihon Shinkettukan. Intervention Gakkai Gakujutu Iinkai. Dai 12 kai nihon shinkettukan intervention gakkai gakujutu iinkai anke-to kekka. Jan J Interv Cardiol. 2004;19:15–21 (in Japanese).
Weissman IA, Dickinson CZ, Dworkin HJ, O’Neill WW, Juni JE. Cost-effectiveness of myocardial perfusion imaging with SPECT in the emergency department evaluation of patients with unexplained chest pain. Radiology. 1996;199:353–7.
Des Prez RD, Shaw LJ, Gillespie RL, Jaber WA, Noble GL, Soman P, Wolinsky DG, Williams KA. Cost-effectiveness of myocardial perfusion imaging: a summary of the currently available literature. J Nucl Cardiol. 2005;12:750–9.
Maddahi J, Iskandrian AE. Cost-effectiveness of nuclear cardiology. J Nucl Cardiol. 1997;4:S139–40.
Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation. 1995;91:54–65.
Hachamovitch R, Berman DS, Kiat H. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation. 2002;105:823–9.
Pilz G, Jeske A, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P. Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging. Am J Cardiol. 2008;101:1408–12.
Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, Fleck E, Paetsch I. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115:1769–76.
Ingkanisorn WP, Kwong RY, Bohme NS, Geller NL, Rhoads KL, Dyke CK, Paterson DI, Syed MA, Aletras AH, Arai AE. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol. 2006;47:1427–32.
Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716–21.
Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med. 1999;130:719–28.
Min JK, Gilmore A, Budoff MJ, Berman DS, O’Day K. Cost-effectiveness of coronary CT angiography versus myocardial perfusion SPECT for evaluation of patients with chest pain and no known coronary artery disease. Radiology. 2010;254:801–8.
Ladapo JA, Hoffmann U, Bamberg F, Nagurney JT, Cutler DM, Weinstein MC, Gazelle GS. Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR. 2008;191:455–63.
Stacul F, Sironi D, Grisi G, Belgrano M, Salvi A, Cova M. 64-Slice CT coronary angiography versus conventional coronary angiography: activity-based cost analysis. Radiol Med. 2009;114:239–52.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Iwata, K., Ogasawara, K. Comparison of the cost-effectiveness of stress myocardial perfusion MRI and SPECT in patients with suspected coronary artery disease. Radiol Phys Technol 6, 28–34 (2013). https://doi.org/10.1007/s12194-012-0165-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12194-012-0165-2